Two-day seven-day course of levofloxacin in acute COPD exacerbation: a randomized controlled trial
Introduction: Duration of antibiotic treatment in acute exacerbation of COPD (AECOPD) is most commonly based on expert opinion. Typical administration periods range from 5 to 7 days. A 2-day course with levofloxacin was not previously assessed. We performed a randomized clinical trial to evaluate th...
Main Authors: | Salma Messous, Imen Trabelsi, Khaoula Bel Haj Ali, Ahmed Abdelghani, Yosra Ben Daya, Rabie Razgallah, Mohamed Habib Grissa, Kaouthar Beltaief, Zied Mezgar, Asma Belguith, Wahid Bouida, Riadh Boukef, Hamdi Boubaker, Mohamed Amine Msolli, Adel Sekma, Semir Nouira |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2022-06-01
|
Series: | Therapeutic Advances in Respiratory Disease |
Online Access: | https://doi.org/10.1177/17534666221099729 |
Similar Items
-
2-Day versus C-reactive protein guided antibiotherapy with levofloxacin in acute COPD exacerbation: A randomized controlled trial.
by: Msolli Mohamed Amine, et al.
Published: (2021-01-01) -
Pulse amplitude ratio under noninvasive ventilation as a new method in the diagnosis of left heart failure in patients with acute exacerbation of chronic obstructive pulmonary disease
by: Khaoula Bel Haj Ali, et al.
Published: (2023-02-01) -
30 day predicted outcome in undifferentiated chest pain: multicenter validation of the HEART score in Tunisian population
by: Mohamed Hassene Khalil, et al.
Published: (2021-11-01) -
Appropriateness of antibiotic treatment of acute respiratory tract infections in Tunisian primary care and emergency departments: a multicenter cross-sectional study
by: Khaoula Bel Haj Ali, et al.
Published: (2022-11-01) -
Value of early change of serum C reactive protein combined to modified Alvarado score in the diagnosis of acute appendicitis
by: Mohamed Amine Msolli, et al.
Published: (2018-05-01)